Medical Doctor
Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany, Germany
Jan H. Frenking, MD, has been a resident in the Department of Hematology, Oncology and Rheumatology (Internal Medicine V) at Heidelberg University Hospital since November 2021. He studied medicine in Freiburg and received his license to practice medicine in June 2021. Due to his strong interest in microenvironment research and novel immunotherapeutic approaches, his clinical and scientific work focuses on T cell redirecting therapies in the context of multiple myeloma. As a physician scientist, he is a member of the Clinical Cooperation Unit 'Molecular Hematology/Oncology' at the German Cancer Research Center.